Unique platform
MMTs discovery platform
PleoBOTTM platform
Biologically validated
At the heart of innovation, Tangramed's unique proprietary AI platform has been specifically designed to generate new drug combination candidates based on a different and relevant scientific approach.
​​
The AI-generated MMTs are validated on some of the most advanced preclinical techniques on the market.
Not only to assess their efficacy, but also to constantly optimize the PleoBOTTM platform and generate even more relevant and promising combinations.
Tackling complex diseases with unmet medical needs requires a synergistic approach, involving multiple modes of action. However, the combinatorial nature of the problem often makes efficient discovery financially challenging.
Tangramed platform, seamlessly integrating AI and advanced preclinical tests, allows to identify efficient MMTs and optimizes discovery success rates and cost efficiency. Through continuous evolution, the platform self-improves as experimental results train AI smarter, and AI, along with an expert system, designs new experimental tests.
